Notice of General Meeting Sydney, Australia, 31 July 2026: Recce Pharmaceuticals Limited ( ASX:RCE, FSE:R9Q ) (the Company ), attaches the following documents in relation to its General Meeting to be held at 10:00AM (AEST) on Wednesday, 2 September 2026: 1. Notice of...
Recce Pharmaceuticals: Notice of General Meeting/Proxy Form
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Recce Pharmaceuticals
- U.S. Government Releases US$66.9B AMR Biodefense Strategy
- Vietnamese Patent Granted for RECCE Anti-Infectives
- AUD $3.7M Income Tax Refund Received
- Placement & SPP to raise $8 million
- HREC Approval Accelerates Global Phase 3 DFI Strategy
Later from Recce Pharmaceuticals
- Application for quotation of securities - RCE
- Completion of Share Purchase Plan and Shortfall Notice
- Cleansing Notice
- Change of Director's Interest Notices (x4)
- HREC Approves Comparator Study for Pivotal Phase 3 DFI
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals